A moment's pause: Putative nucleosome-based influences on MeCP2 regulation

Biochemistry and Cell Biology

Volumn 87, Issue 5, 2009, Pages 791-798

  Thambirajah, Anita A ^a   Ausió, Juan ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Chromatin; Histone variants; MeCP2; Post translational modifications; Rett syndrome

Indexed keywords

CHROMATIN; HISTONE VARIANTS; MECP2; POST-TRANSLATIONAL MODIFICATIONS; RETT SYNDROME;

EQUATIONS OF STATE; LAWS AND LEGISLATION; PROTEINS;

CHROMOSOMES;

METHYL CPG BINDING PROTEIN 2;

BRAIN TISSUE; CHROMATIN; CONFERENCE PAPER; DYNAMICS; HUMAN; NONHUMAN; NUCLEOSOME; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGULATORY MECHANISM;

ANIMALS; BINDING SITES; GENE EXPRESSION REGULATION; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MODELS, BIOLOGICAL; NUCLEOSOMES; REGULATORY SEQUENCES, NUCLEIC ACID; RETT SYNDROME; TIME FACTORS;

EID: 70349687410     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/O09-054     Document Type: Conference Paper

References (73)

1. Adams, V.H., McBryant, S.J., Wade, P.A., Woodcock, C.L., and Hansen, J.C. 2007. Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2. J. Biol. Chem. 282(20): 15057-15064. doi:10.1074/jbc.M700855200. PMID:17371874.
2. Agarwal, N., Hardt, T., Brero, A., Nowak, D., Rothbauer, U., Becker, A., et al. 2007. MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation. Nucleic Acids Res. 35(16): 5402-5408. doi:10.1093/nar/gkm599. PMID:17698499. (Pubitemid 47423914)
3. Armstrong, D.D., Dunn, K., and Antalffy, B. 1998. Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J. Neuropathol. Exp. Neurol. 57(11): 1013-1017. doi:10.1097/ 00005072-199811000-00003. PMID:9825937.
4. Ausio, J. 2006. Histone variants - the structure behind the function. Brief. Funct. Genomic. Proteomic. 5(3): 228-243. doi:10.1093/bfgp/ell020. PMID:16772274.
5. Ballas, N., Lioy, D.T., Grunseich, C., and Mandel, G. 2009. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat. Neurosci. 12(3): 311-317. doi:10.1038/nn.2275. PMID:19234456.
6. Balmer, D., Arredondo, J., Samaco, R.C., and LaSalle, J.M. 2002. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum. Genet. 110(6): 545-552. doi:10.1007/s00439-002-0724-4. PMID:12107440.
7. Benevolenskaya, E.V. 2007. Histone H3K4 demethylases are essential in development and differentiation. Biochem. Cell Biol. 85(4): 435-443. doi:10.1139/O07-057. PMID:17713579.
8. Brero, A., Easwaran, H.P., Nowak, D., Grunewald, I., Cremer, T., Leonhardt, H., and Cardoso, M.C. 2005. Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation. J. Cell Biol. 169(5): 733-743. doi:10.1083/jcb.200502062. PMID:15939760. (Pubitemid 41002879)
9. Bruce, K., Myers, F.A., Mantouvalou, E., Lefevre, P., Greaves, I., Bonifer, C., et al. 2005. The replacement histone H2A.Z in a hyperacetylated form is a feature of active genes in the chicken. Nucleic Acids Res. 33(17): 5633-5639. doi:10.1093/nar/gki874. PMID:16204459. (Pubitemid 41548829)
10. Buschdorf, J.P., and Strätling, W.H. 2004. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome. J. Mol. Med. 82(2): 135-143. doi:10.1007/s00109-003-0497-9. PMID:14618241.
11. Chahrour, M., Jung, S.Y., Shaw, C., Zhou, X., Wong, S.T., Qin, J., and Zoghbi, H.Y. 2008. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science, 320(5880): 1224-1229. doi:10.1126/science. 1153252. PMID: 18511691. (Pubitemid 351929512)
12. Chen, W.G., Chang, Q., Lin, Y., Meissner, A., West, A.E., Griffith, E.C., et al. 2003. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science, 302(5646): 885-889. doi:10.1126/science. 1086446. PMID: 14593183. (Pubitemid 37339632)
13. Collins, A.L., Levenson, J.M., Vilaythong, A.P., Richman, R., Armstrong, D.L., Noebels, J.L., et al. 2004. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13(21): 2679-2689. doi:10.1093/hmg/ddh282. PMID:15351775.
14. Crowe, S.L., Movsesyan, V.A., Jorgensen, T.J., and Kondratyev, A. 2006. Rapid phosphorylation of histone H2A.X following ionotropic glutamate receptor activation. Eur. J. Neurosci. 23(9): 2351-2361. doi:10.1111/j.1460-9568.2006. 04768.x. PMID: 16706843.
15. Delcuve, G.P., Rastegar, M., and Davie, J.R. 2009. Epigenetic control. J. Cell. Physiol. 219(2): 243-250. doi:10.1002/jcp.21678. PMID:19127539.
16. Fischle, W. 2008. Talk is cheap-cross-talk in establishment, maintenance, and readout of chromatin modifications. Genes Dev. 22(24): 3375-3382. doi:10.1101/gad.1759708. PMID:19141469.
17. Fuks, F., Hurd, P.J., Wolf, D., Nan, X., Bird, A.P., and Kouzarides, T. 2003. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278(6): 4035-4040. doi:10.1074/jbc.M210256200. PMID:12427740.
18. Galvão, T.C., and Thomas, J.O. 2005. Structure-specific binding of MeCP2 to four-way junction DNA through its methyl CpG-binding domain. Nucleic Acids Res. 33(20): 6603-6609. doi:10.1093/nar/gki971. PMID:16314321.
19. Gan, Q., Yoshida, T., McDonald, O.G., and Owens, G.K. 2007. Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Stem Cells, 25(1): 2-9. doi:10.1634/stemcells.2006-0383. PMID:17023513. (Pubitemid 46052969)
20. Georgel, P.T., Horowitz-Scherer, R.A., Adkins, N., Woodcock, C.L., Wade, P.A., and Hansen, J.C. 2003. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J. Biol. Chem. 278(34): 32181-32188. doi:10.1074/jbc.M305308200. PMID: 12788925.
21. Hagberg, B., Aicardi, J., Dias, K., and Ramos, O. 1983. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann. Neurol. 14(4): 471-479. doi:10.1002/ana.410140412. PMID: 6638958.
22. Harikrishnan, K.N., Chow, M.Z., Baker, E.K., Pal, S., Bassal, S., Brasacchio, D., et al. 2005. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat. Genet. 37(3): 254-264. doi:10.1038/ng1516. PMID:15696166.
23. Heitmann, B., Maurer, T., Weitzel, J.M., Strätling, W.H., Kalbitzer, H.R., and Brunner, E. 2003. Solution structure of the matrix attachment region-binding domain of chicken MeCP2. Eur. J. Biochem. 270(15): 3263-3270. doi:10.1046/j.1432-1033.2003.03714.x. PMID:12869202.
24. Hendrich, B., and Bird, A. 1998. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18(11): 6538-6547. PMID:9774669.
25. Henikoff, S., Henikoff, J.G., Sakai, A., Loeb, G.B., and Ahmad, K. 2009. Genome-wide profiling of salt fractions maps physical properties of chromatin. Genome Res. 19(3): 460-469. doi:10.1101/gr.087619.108. PMID:19088306.
26. Ho, K.L., McNae, I.W., Schmiedeberg, L., Klose, R.J., Bird, A.P., and Walkinshaw, M.D. 2008. MeCP2 binding to DNA depends upon hydration at methyl-CpG. Mol. Cell, 29(4): 525-531. doi:10.1016/j.molcel.2007.12.028. PMID:18313390.
27. Hu, K., Nan, X., Bird, A., and Wang, W. 2006. Testing for association between MeCP2 and the brahma-associated SWI/SNF chromatin-remodeling complex. Nat. Genet. 38(9): 962-964, author reply 964-967. doi:10.1038/ng0906-962. PMID:16940996.
28. Isaacs, J.S., Murdock, M., Lane, J., and Percy, A.K. 2003. Eating difficulties in girls with Rett syndrome compared with other developmental disabilities. J. Am. Diet. Assoc. 103(2): 224-230. doi:10.1053/jada.2003.50026. PMID:12589330.
29. Ishibashi, T., Thambirajah, A.A., and Ausió, J. 2008. MeCP2 preferentially binds to methylated linker DNA in the absence of the terminal tail of histone H3 and independently of histone acetylation. FEBS Lett. 582(7): 1157-1162. doi:10.1016/j.febslet.2008.03.005. PMID:18339321.
30. Jenuwein, T., and Allis, C.D. 2001. Translating the histone code. Science, 293(5532): 1074-1080. doi:10.1126/science.1063127. PMID:11498575.
31. Jiang, Y., Langley, B., Lubin, F.D., Renthal, W., Wood, M.A., Yasui, D.H., et al. 2008. Epigenetics in the nervous system. J. Neurosci. 28(46): 11753-11759. doi:10.1523/JNEUROSCI.3797-08.2008. PMID:19005036.
32. Jones, P.L., Veenstra, G.J., Wade, P.A., Vermaak, D., Kass, S.U., Landsberger, N., et al. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19(2): 187-191. doi:10.1038/561. PMID:9620779.
33. Jugloff, D.G., Jung, B.P., Purushotham, D., Logan, R., and Eubanks, J.H. 2005. Increased dendritic complexity and axonal length in cultured mouse cortical neurons overexpressing methyl-CpG-binding protein MeCP2. Neurobiol. Dis. 19(1-2): 18-27. doi:10.1016/j.nbd.2004.11.002. PMID:15837557.
34. Kaufmann, W.E., Jarrar, M.H., Wang, J.S., Lee, Y.J., Reddy, S., Bibat, G., and Naidu, S. 2005. Histone modifications in Rett syndrome lymphocytes: a preliminary evaluation. Brain Dev. 27(5): 331-339. doi:10.1016/j.braindev.2004. 09.005. PMID: 16023547. (Pubitemid 40991752)
35. Klose, R.J., Sarraf, S.A., Schmiedeberg, L., McDermott, S.M., Stancheva, I., and Bird, A.P. 2005. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell, 19(5): 667-678. doi:10.1016/j.molcel.2005.07.021. PMID:16137622.
36. Koch, C., and Strätling, W.H. 2004. DNA binding of methyl-CpG-binding protein MeCP2 in human MCF7 cells. Biochemistry, 43(17): 5011-5021. doi:10.1021/bi0359271. PMID:15109260. (Pubitemid 38544455)
37. Kriaucionis, S., and Bird, A. 2004. The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res. 32(5): 1818-1823. doi:10.1093/nar/gkh349. PMID: 15034150. (Pubitemid 38832727)
38. Kumar, A., Kamboj, S., Malone, B.M., Kudo, S., Twiss, J.L., Czymmek, K.J., et al. 2008. Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo. J. Cell Sci. 121(Pt 7): 1128-1137. doi:10.1242/jcs.016865. PMID:18334558. (Pubitemid 351639431)
39. Leuba, S.H., Bustamante, C., van Holde, K., and Zlatanova, J. 1998. Linker histone tails and N-tails of histone H3 are redundant: scanning force microscopy studies of reconstituted fibers. Biophys. J. 74(6): 2830-2839. doi:10.1016/S0006-3495(98)77990-1. PMID:9635737. (Pubitemid 28268107)
40. Lewis, J.D., Meehan, R.R., Henzel, W.J., Maurer-Fogy, I., Jeppesen, P., Klein, F., and Bird, A. 1992. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69(6): 905-914. doi:10.1016/0092-8674(92)90610-O. PMID:1606614.
41. Lomen-Hoerth, C., and Shooter, E.M. 1995. Widespread neurotrophin receptor expression in the immune system and other nonneuronal rat tissues. J. Neurochem. 64(4): 1780-1789. PMID: 7891106.
42. Marchi, M., Guarda, A., Bergo, A., Landsberger, N., Kilstrup-Nielsen, C., Ratto, G.M., and Costa, M. 2007. Spatio-temporal dynamics and localization of MeCP2 and pathological mutants in living cells. Epigenetics, 2(3): 187-197. PMID:17965612. (Pubitemid 350200397)
43. Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., et al. 2003. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science, 302(5646): 890-893. doi:10.1126/science.1090842. PMID:14593184. (Pubitemid 37339633)
44. Meehan, R.R., Lewis, J.D., and Bird, A.P. 1992. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res. 20(19): 5085-5092. doi:10.1093/nar/20.19.5085. PMID:1408825.
45. Meneghini, M.D., Wu, M., and Madhani, H.D. 2003. Conserved histone variant H2A.Z protects euchromatin from the ectopic spread of silent heterochromatin. Cell, 112(5): 725-736. doi:10.1016/S0092-8674(03)00123-5. PMID:12628191. (Pubitemid 36331783)
46. Métivier, R., Gallais, R., Tiffoche, C., Le Péron, C., Jurkowska, R.Z., Carmouche, R.P., et al. 2008. Cyclical DNA methylation of a transcriptionally active promoter. Nature, 452(7183): 45-50. doi:10.1038/nature06544. PMID:18322525. (Pubitemid 351355084)
47. Miyake, K., and Nagai, K. 2007. Phosphorylation of methyl-CpG binding protein 2 (MeCP2) regulates the intracellular localization during neuronal cell differentiation. Neurochem. Int. 50(1): 264-270. doi:10.1016/j.neuint.2006.08. 018. PMID:17052801.
48. Mnatzakanian, G.N., Lohi, H., Munteanu, I., Alfred, S.E., Yamada, T., MacLeod, P.J., et al. 2004. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat. Genet. 36(4): 339-341. doi:10.1038/ng1327. PMID:15034579.
49. Nan, X., Meehan, R.R., and Bird, A. 1993. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res. 21(21): 4886-4892. doi:10.1093/nar/21.21.4886. PMID:8177735. (Pubitemid 23330162)
50. Nan, X., Campoy, F.J., and Bird, A. 1997. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88(4): 471-481. doi:10.1016/S0092-8674(00)81887-5. PMID:9038338. (Pubitemid 27154412)
51. Nan, X., Ng, H.H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisenman, R.N., and Bird, A. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393(6683): 386-389. doi:10.1038/30764. PMID:9620804. (Pubitemid 28269714)
52. Nikitina, T., Ghosh, R.P., Horowitz-Scherer, R.A., Hansen, J.C., Grigoryev, S.A., and Woodcock, C.L. 2007. MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome. J. Biol. Chem. 282(38): 28237-28245. doi:10.1074/jbc. M704304200. PMID:17660293.
53. 2+ in human airway smooth muscle. Am J Respir Cell Mol Biol. doi:10.1074/jbc.M704304200. PMID:19213875.
54. Probst, A.V., Dunleavy, E., and Almouzni, G. 2009. Epigenetic inheritance during the cell cycle. Nat. Rev. Mol. Cell Biol. 10(3): 192-206. doi:10.1038/nrm2640. PMID:19234478.
55. Raisner, R.M., Hartley, P.D., Meneghini, M.D., Bao, M.Z., Liu, C.L., Schreiber, S.L., et al. 2005. Histone variant H2A.Z marks the 5′ ends of both active and inactive genes in euchromatin. Cell, 123(2): 233-248. doi:10.1016/j.cell.2005.10.002. PMID: 16239142.
56. Rett, A. 1966. [On a unusual brain atrophy syndrome in hyperammonemia in childhood]. Wien. Med. Wochenschr. 116(37): 723-726. PMID:5300597.
57. Shahbazian, M.D., Antalffy, B., Armstrong, D.L., and Zoghbi, H.Y. 2002. Insight into Rett syndrome: MeCP2 levels display tissueand cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 11(2): 115-124. doi:10.1093/hmg/11.2.115. PMID:11809720.
58. Shogren-Knaak, M., Ishii, H., Sun, J.M., Pazin, M.J., Davie, J.R., and Peterson, C.L. 2006. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science, 311(5762): 844-847. doi:10.1126/science.1124000. PMID: 16469925. (Pubitemid 43228847)
59. Soshnikova, N., and Duboule, D. 2008. Epigenetic regulation of Hox gene activation: the waltz of methyls. Bioessays, 30(3): 199-202. doi:10.1002/bies.20724. PMID:18293357. (Pubitemid 351341123)
60. Suzuki, M., Yamada, T., Kihara-Negishi, F., Sakurai, T., and Oikawa, T. 2003. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression. Oncogene, 22(54): 8688-8698. doi:10.1038/sj.onc.1207182. PMID:14647463. (Pubitemid 38010492)
61. Tao, J., Hu, K., Chang, Q., Wu, H., Sherman, N.E., Martinowich, K., et al. 2009. Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proc Natl Acad Sci U S A. 106(12): 4882-4887. PMID:19225110.
62. Thambirajah, A.A., Eubanks, J.H., and Ausió, J. 2009 a. MeCP2 post-translational regulation through PEST domains: two novel hypotheses: potential relevance and implications for Rett syndrome. Bioessays, 31(5): 561-569. doi:10.1002/bies.200800220. PMID:19319913.
63. Thambirajah, A.A., Li, A., Ishibashi, T., and Ausió, J. 2009b. New developments in post-translational modifications and functions of histone H2A variants. Biochem. Cell Biol. 87(1): 7-17. doi:10.1139/O08-103. PMID:19234519.
64. Tost, J. 2009. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Methods Mol Biol. 507: 3-20. doi:10.1016/0022-5193(71)90059-2. PMID:5555592.
65. Tsanev, R., and Sendov, B. 1971. Possible molecular mechanism for cell differentiation in multicellular organisms. J. Theor. Biol. 30(2): 337-393. doi:10.1016/0022-5193(71)90059-2. PMID:5555592.
66. Urdinguio, R.G., Pino, I., Ropero, S., Fraga, M.F., and Esteller, M. 2007. Histone H3 and H4 modification profiles in a Rett syndrome mouse model. Epigenetics, 2(1): 11-14. PMID:17965622. (Pubitemid 46824844)
67. Vasko, M.R., Guo, C., and Kelley, M.R. 2005. The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress. DNA Repair (Amst.), 4(3): 367-379. doi:10.1016/j.dnarep.2004.11.006. PMID:15661660. (Pubitemid 40127000)
68. Wakefield, R.I., Smith, B.O., Nan, X., Free, A., Soteriou, A., Uhrin, D., et al. 1999. The solution structure of the domain from MeCP2 that binds to methylated DNA. J. Mol. Biol. 291(5): 1055-1065. doi:10.1006/jmbi.1999.3023. PMID:10518942.
69. Wan, M., Zhao, K., Lee, S.S., and Francke, U. 2001. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome. Hum. Mol. Genet. 10(10): 1085-1092. doi:10.1093/hmg/10.10.1085. PMID:11331619.
70. Wu, J.I., Lessard, J., and Crabtree, G.R. 2009. Understanding the words of chromatin regulation. Cell, 136(2): 200-206. doi:10.1016/j.cell.2009.01.009. PMID:19167321.
71. Yasui, D.H., Peddada, S., Bieda, M.C., Vallero, R.O., Hogart, A., Nagarajan, R.P., et al. 2007. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc. Natl. Acad. Sci. U.S.A. 104(49): 19416-19421. doi:10.1073/pnas.0707442104. PMID:18042715.
72. Young, J.I., Hong, E.P., Castle, J.C., Crespo-Barreto, J., Bowman, A.B., Rose, M.F., et al. 2005. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl. Acad. Sci. U.S.A. 102(49): 17551-17558. doi:10.1073/pnas.0507856102. PMID:16251272.
73. Zhou, Z., Hong, E.J., Cohen, S., Zhao, W.N., Ho, H.Y., Schmidt, L., et al. 2006. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron, 52(2): 255-269. doi:10.1016/j.neuron.2006.09.037. PMID:17046689. (Pubitemid 44548348)